Panel Discussion | What Does the Future Hold for LAA Closure?

Saturday, March 8, 2025

5:23 PM - 5:50 PM ET

Panel Moderator(s)

Stefan Bertog, MD

Cardioligist
CardioVascular Center Frankfurt
St Paul, Minnesota, United States

Disclosure information not submitted.
Kenneth A. Ellenbogen, MD

Professor
VCU School of Medicine
Richmond, Virginia, United States

Disclosure(s): No financial relationships to disclose
Michael J. Rinaldi, MD

Director Structural Heart Program
Sanger Heart and Vascular Institute/Atrium Health
Charlotte, North Carolina, United States

Disclosure information not submitted.

Panel Discussant(s)

Mehmet Cilingiroglu, MD

Professor
UT Houston MD Anderson Cancer Center
San Diego, California, United States

No relationships to disclose
Kenneth A. Ellenbogen, MD

Professor
VCU School of Medicine
Richmond, Virginia, United States

Disclosure(s): No financial relationships to disclose
William A. Gray, MD, FSCAI

System Chief of Cardiovascular Services, Main Line Health/President, Lankenau Heart Institute
Main Line Health
Wynnewood, Pennsylvania, United States

Disclosure information not submitted.
Srinivas Iyengar, MD

Director, Structural Heart
Boulder Heart at Anderson Medical Center (Boulder Community Health), Colorado, United States

No relationships to disclose
Vijay Iyer, MD, PhD

Associate Professor
University at Buffalo
East Amherst, New York, United States

No relationships to disclose
Aaron V. Kaplan, MD, FSCAI, FACC, FNAI

Professor of Medicine
Dartmouth Health Geisel School of Medicine at Dartmouth
Lebanon, New Hampshire, United States

Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Grant/Research Support (Ongoing); Conformal Medical, Inc.: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Horst Sievert, MD, FSCAI, FACC, FESC

Director
CardioVascular Center Frankfurt CVC
Frankfurt, Hessen, Germany

No relationships to disclose
Thomas Waggoner, DO, FACC, FSCAI, FSVM, RPVI

Director Structural Heart, Director Cardiovascular Research, Direct Advanced Cardiac Fellowships.
US Heart & Vascular, Tucson Medical Center

No relationships to disclose

Disclosure(s):

Stefan Bertog, MD: Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing)

Kenneth A. Ellenbogen, MD: No financial relationships to disclose

Michael J. Rinaldi, MD: Abbott Vascular,: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); abiomed: Consultant (Ongoing); boston scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); edwards: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); shockwave: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Mehmet Cilingiroglu, MD: No financial relationships to disclose

William A. Gray, MD, FSCAI: Abbott Vascular, Medtronic, Boston Scientific: Grant/Research Support (Ongoing)

Srinivas Iyengar, MD: No financial relationships to disclose

Vijay Iyer, MD, PhD: No financial relationships to disclose

Aaron V. Kaplan, MD, FSCAI, FACC, FNAI: Abbott Vascular, Medtronic, Boston Scientific: Grant/Research Support (Ongoing); Conformal Medical, Inc.: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Vivian Ng, MD: Boston scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing); Medtronic: Consultant (Ongoing); xDOT: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Horst Sievert, MD, FSCAI, FACC, FESC: Abbott, Ablative Solutions, Adona Medical, Akura Medical, Ancora Heart, Append Medical, Axon, Bavaria Medizin Technologie GmbH, BioRefine, Bioventrix, Boston Scientific, Canon, Cardiac Dimensions, Cardiac Success, Cardimed, Cardionovum, Contego: Study honoraria to institution, travel expenses, consulting fees (Ongoing); Coramaze, Croivalve, CSL Behring LLC, CVRx, Dinova, Endobar, Endologix, Endomatic, Esperion Therapeutics, Inc., Hangzhou Nuomao Medtech, Holistick Medical, Intershunt, Intervene, K2, Laminar, Lifetech: Study honoraria to institution, travel expenses, consulting fees (Ongoing); Magenta, Maquet Getinge Group, Metavention, Mitralix, Mokita, Myotec, Neurotronic, Novelrad, NXT Biomedical, Occlutech, Recor, Renal Guard, Shifamed, Terumo, Tonic Medical: Study honoraria to institution, travel expenses, consulting fees (Ongoing); Trisol, TruLeaf, Vascular Dynamics, Vectorious Medtech, Venus, Venock, Vivasure Medical, Vvital Biomed, Whiteswell, Xenter: Study honoraria to institution, travel expenses, consulting fees (Ongoing)

Thomas Waggoner, DO, FACC, FSCAI, FSVM, RPVI: No financial relationships to disclose

Oussama Wazni, MD. MBA.: Biosense Webster, Inc: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scietific: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); GE Healthcare: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); medtronic.: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)